The Current Ratio as of December 2025 (TTM) for Citius Oncology, Inc. (CTOR) is 0.35

According to Citius Oncology, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.35. This represents a change of -3.84% compared to the average of 0.36 of the last 4 quarters.

Citius Oncology, Inc. (CTOR) Historical Current Ratio (quarterly & annually)

How has CTOR Current Ratio performed in the past?

The mean historical Current Ratio of Citius Oncology, Inc. over the last ten years is 0.29. The current 0.35 Current Ratio has changed 11.78% with respect to the historical average. Over the past ten years (40 quarters), CTOR's Current Ratio was at its highest in in the December 2022 quarter at 11.85. The Current Ratio was at its lowest in in the April 2021 quarter at 0.

Citius Oncology, Inc. (CTOR) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Citius Oncology, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Citius Oncology, Inc. (CTOR) Average Current Ratio

How has CTOR Current Ratio performed in the past?

The current Current Ratio of Citius Oncology, Inc. (CTOR) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Citius Oncology, Inc. (CTOR) Current Ratio vs. Peers

How is CTOR’s Current Ratio compared to its peers?

Citius Oncology, Inc.’s Current Ratio is greater than Scilex Holding Company (0.05), less than Actuate Therapeutics Inc (2.74), less than Forte Biosciences, Inc. (7.34), less than Spero Therapeutics, Inc. (3.83), less than Applied Therapeutics, Inc. (0.96), less than Vor Biopharma Inc. (9.16), less than Seres Therapeutics, Inc. (2.30), less than Fate Therapeutics, Inc. (7.87), less than LENSAR, Inc. (1.52), less than Owlet, Inc. (1.14),

Build a custom stock screener for Citius Oncology, Inc. (CTOR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Citius Oncology, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Citius Oncology, Inc. (CTOR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Citius Oncology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.